GSDMD and rheumatoid arthritis: A recent study from Zhang and his team demonstrated that complement C1q synergises with pentraxin 3 (PTX3) in promoting NLRP3 overactivation, ultimately resulting in GSDMD‐mediated monocyte pyroptosis and excessive inflammatory cytokine release in RA.